Jie Zuo

Key Laboratory Of Northwest Water Resource
Xi'an, 710055, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Pre-exposure of peracetic acid enhances its subsequent combination with ultraviolet for the inactivation of fungal spores: Efficiency, mechanisms, and implications.

Pre-exposure of peracetic acid enhances its subsequent combination with ultraviolet for the inactivation of fungal spores: Efficiency, mechanisms, and implications.

Journal: Water research
Published: August 02, 2022

Effective inactivation of fungal spores by the combined UV/PAA: Synergistic effect and mechanisms.

Effective inactivation of fungal spores by the combined UV/PAA: Synergistic effect and mechanisms.

Journal: Journal of hazardous materials
Published: November 21, 2021

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.

Journal: CNS neuroscience & therapeutics
Published: October 04, 2019

WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

Journal: Biochemical and biophysical research communications
Published: October 02, 2019

Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.

Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.

Journal: CNS neuroscience & therapeutics
Published: August 16, 2019

Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.

Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.

Journal: Pathology, research and practice
Published: June 21, 2019

Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.

Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.

Journal: Pathology, research and practice
Published: June 02, 2019

Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.

Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.

Journal: Life sciences
Published: May 28, 2019

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.

Journal: CNS neuroscience & therapeutics
Published: May 23, 2019

Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.

Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.

Journal: Oncology reports
Published: September 03, 2018

Nogo-B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma.

Nogo-B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma.

Journal: Molecular oncology
Published: February 07, 2018

TCP10L synergizes with MAD1 in transcriptional suppression and cell cycle arrest through mutual interaction.

TCP10L synergizes with MAD1 in transcriptional suppression and cell cycle arrest through mutual interaction.

Journal: BMB reports
Published: November 30, 2015
Showing 1-12 of 19

Last Updated: 09/26/2026